| Literature DB >> 26504007 |
Tatsuya Yoshimasu1, Takuya Ohashi2, Shoji Oura2, Yozo Kokawa2, Mitsumasa Kawago2, Yoshimitsu Hirai2, Miwako Miyasaka2, Haruka Nishiguchi2, Sayoko Kawashima2, Yumi Yata2, Mariko Honda2, Takahiro Fujimoto2, Yoshitaka Okamura2.
Abstract
In the present article, we quantitatively evaluated the dose-response relationship of hormetic reactions of anticancer agents in vitro. Serial dilutions of gemcitabine, cisplatin, 5-fluorouracil, vinorelbine, and paclitaxel were administered to the A549 non-small-cell lung cancer cell line. The bi-phasic sigmoidal curve with hormetic and cytotoxic effects is given by the formula y=(a-b/(1+exp(c(*)log(x)-d)))/(1+exp(e(*)log(x)-f)), that was used to perform a non-linear least square regression. The dose-responses of the five anticancer agents were fitted to this equation. Gemcitabine and 5-fluorouracil, which had the lowest ED50 for their hormetic reaction, had the most pronounced promotive effects out of the five anticancer agents tested. The hormetic reaction progressed exponentially with culturing time. Our theoretical model will be useful in predicting how hormetic reactions affect patients with malignant tumors. CopyrightEntities:
Keywords: Hormesis; chemotherapy; lung cancer
Mesh:
Substances:
Year: 2015 PMID: 26504007
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480